The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET)

2024-512301-16-01 Protocol 23U-0502 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 12 Dec 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol 23U-0502

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 25
Countries 1
Sites 1

Metastatic colorectal cancer

Key facts

Sponsor
Universitair Medisch Centrum Utrecht
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01], Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05], Diseases [C] - Digestive System Diseases [C06]
Trial duration
12 Dec 2024 → ongoing
Decision date (initial)
2024-08-19
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Metastatic colorectal cancer

VersionLevelCodeTermSystem organ class
21.0 PT 10052358 Colorectal cancer metastatic 100000004864

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Universitair Medisch Centrum Utrecht

Sponsor organisation
Universitair Medisch Centrum Utrecht
Address
Heidelberglaan 100
City
Utrecht
Postcode
3584 CX
Country
Netherlands

Scientific contact point

Organisation
Universitair Medisch Centrum Utrecht
Contact name
M. van den Bos

Public contact point

Organisation
Universitair Medisch Centrum Utrecht
Contact name
M. van den Bos

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 25 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ongoing, recruiting
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Nuclear Medicine, Plesmanlaan 121, 1066 CX, Amsterdam

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2024-12-12 2025-01-13

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-04-23 Netherlands Acceptable with conditions
2024-08-12
2024-08-19
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-12-22 Netherlands Acceptable with conditions
2024-08-12
2025-12-22
3 NON SUBSTANTIAL MODIFICATION NSM-2 2025-12-24 Netherlands Acceptable with conditions
2024-08-12
2025-12-24
4 NON SUBSTANTIAL MODIFICATION NSM-3 2026-02-18 Netherlands Acceptable with conditions
2024-08-12
2026-02-18
5 NON SUBSTANTIAL MODIFICATION NSM-4 2026-03-03 Netherlands Acceptable with conditions
2024-08-12
2026-03-03